Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Clotet

Showing results (191-200 of 263) with videos related to

Pageof 27
Sort By:
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
Journal of Viral Hepatitis|March 29, 2014
Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patientsM Nevot, C Boesecke, M Parera, et al.
AIDS (London, England)|June 16, 2001
Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavirO Kirk, A Mocroft, C Pradier, et al.
HIV Medicine|May 7, 2015
Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 yearsE Negredo, A Bonjoch, N Pérez-Álvarez, et al.
AIDS (London, England)|September 1, 1996
Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 x 10(6)/lL Ruiz, J Romeu, B Clotet, et al.
HIV Medicine|November 20, 2013
Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baselineR Sanmartín, J Tor, A Sanvisens, et al.
Antiviral Therapy|May 15, 2002
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA studyA Mocroft, A N Phillips, N Friis-Møller, et al.
Medicina Clinica|April 18, 1987
[T lymphocyte subpopulations, markers of the HTLV III virus and immunoglobulin levels in asymptomatic homosexuals of the Barcelona area]J Juncà Piera, E Argelagués Vidal, R Cruz Llaüna, et al.
AIDS (London, England)|July 14, 1998
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainM Gómez-Cano, A Rubio, T Puig, et al.
Journal of Medical Virology|July 14, 1998
Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmissionA Ibáñez, M Giménez-Barcons, A Tajahuerce, et al.
Pageof 27

Showing results (191-200 of 263) with videos related to

Sort By:
Pageof 27
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
Journal of Viral Hepatitis|March 29, 2014
Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patientsM Nevot, C Boesecke, M Parera, et al.
AIDS (London, England)|June 16, 2001
Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavirO Kirk, A Mocroft, C Pradier, et al.
HIV Medicine|May 7, 2015
Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 yearsE Negredo, A Bonjoch, N Pérez-Álvarez, et al.
AIDS (London, England)|September 1, 1996
Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 x 10(6)/lL Ruiz, J Romeu, B Clotet, et al.
HIV Medicine|November 20, 2013
Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baselineR Sanmartín, J Tor, A Sanvisens, et al.
Antiviral Therapy|May 15, 2002
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA studyA Mocroft, A N Phillips, N Friis-Møller, et al.
Medicina Clinica|April 18, 1987
[T lymphocyte subpopulations, markers of the HTLV III virus and immunoglobulin levels in asymptomatic homosexuals of the Barcelona area]J Juncà Piera, E Argelagués Vidal, R Cruz Llaüna, et al.
AIDS (London, England)|July 14, 1998
Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in SpainM Gómez-Cano, A Rubio, T Puig, et al.
Journal of Medical Virology|July 14, 1998
Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmissionA Ibáñez, M Giménez-Barcons, A Tajahuerce, et al.
Pageof 27